Phraction Management’s Oracle ORCL Stock Holding History

Phraction Management’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,533	Closed	-$214K	–	80
2025 Q1	$214K	Buy	+1,533	New	+$250K	0.07%	72

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Phraction Management's ORCL Position: Q2 2025 in Review

Phraction Management sold out of Oracle (ORCL) in Q2 2025, closing a stake of 1,533 shares — an estimated $214K sold.

Phraction Management first reported a position in ORCL in Q1 2025 and held it in 1 quarter. The position peaked at $214K in Q1 2025. 3,616 funds tracked by Wall St. Rank hold ORCL as of Q2 2025.

Phraction Management reported no remaining Oracle position as of Q2 2025 after selling out during the quarter.
Phraction Management sold 1,533 Oracle shares in Q2 2025, an estimated $214K.
Phraction Management first reported a position in Oracle in Q1 2025 and held it in 1 quarter.
Phraction Management's Oracle position peaked at $214K in Q1 2025.
3,616 funds tracked by Wall St. Rank held Oracle as of Q2 2025.

Based on Phraction Management's 13F filing for Q2 2025, filed 21 Jul 2025.